Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Plos One|July 28, 2025
Effect of cystic fibrosis transmembrane conductance regulator modulators and dedicated cystic fibrosis gastrointestinal clinic visits on the incidence of distal intestinal obstructive syndrome in persons with cystic fibrosisNicha Wongjarupong, Malique F Delbrune, Jameel Alp, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 31, 2019
Lung transplant referral for individuals with cystic fibrosis: Cystic Fibrosis Foundation consensus guidelinesKathleen J Ramos, Patrick J Smith, Edward F McKone, et al.Pancreas|December 6, 2017
Total Pancreatectomy With Intraportal Islet Autotransplantation as a Treatment of Chronic Pancreatitis in Patients With CFTR MutationsKristin P Colling, Melena D Bellin, Sarah J Schwarzenberg, et al.Patient Education and Counseling|May 10, 2025
Personal narratives to support learning about lung transplant for people with cystic fibrosisDave Young, Lauren E Bartlett, Nick Reid, et al.BMC Pulmonary Medicine|July 18, 2024
Attitudes toward and preparedness for lung transplantation among individuals with cystic fibrosis in the era of highly effective modulatorsNora Burdis, Siddhartha G Kapnadak, Lauren E Bartlett, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 2, 2020
Formative evaluation of a dashboard to support coproduction of healthcare services in cystic fibrosisAricca D Van Citters, Alex H Gifford, Cynthia Brady, et al.American Journal of Respiratory and Critical Care Medicine|April 25, 2018
Effects of an Antioxidant-enriched Multivitamin in Cystic Fibrosis. A Randomized, Controlled, Multicenter Clinical TrialScott D Sagel, Umer Khan, Raksha Jain, et al.The New England Journal of Medicine|November 19, 2010
Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutationFrank J Accurso, Steven M Rowe, J P Clancy, et al.Thorax|August 10, 2011
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutationJ P Clancy, Steven M Rowe, Frank J Accurso, et al.Pageof 3